Avalo Therapeutics, Inc. Common Stock
$16.57
-$0.12 (-0.72%)
$16.34Day Range$16.93
Key Statistics
Market Cap
$895.08M
Shares Outstanding
53.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 13, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$16.66
Day High
$16.93
Day Low
$16.34
Volume
3.23M
VWAP
$16.57
Prev Close
$16.69
Transactions
--
Acc. Volume
--
About Avalo Therapeutics, Inc. Common Stock
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
PHARMACEUTICAL PREPARATIONSSIC 283433 employees1500 LIBERTY RIDGE DRIVE, WAYNE, PA, 19087410-522-8707IPO Nov 13, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001534120
- Composite FIGI
- BBG001QHW0Y8
- Share Class FIGI
- BBG001V1GPQ9
- Ticker Root
- AVTX
- SIC Code
- 2834
About Avalo Therapeutics, Inc. Common Stock (AVTX) Stock
Avalo Therapeutics, Inc. Common Stock (AVTX) closed the 2026-09-18 session at $16.57, down 0.72% versus the previous close (-0.12). The stock opened at $16.66 and traded between $16.34 and $16.93 during that session. Session trading volume was 3.2M shares. The volume-weighted average price (VWAP) is $16.57.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Avalo Therapeutics, Inc. Common Stock has a market capitalization of $895.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. AVTX is listed on the XNAS exchange. The company employs approximately 33 people. Avalo Therapeutics, Inc. Common Stock is headquartered in WAYNE, PA. The recorded listing date is 2015-11-13.
On this page you can find market AVTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.